Bandaram Pharma Financials

BSE: 524602

₹21.55

₹0.39 (1.84%)

As on 03-Sep-2026 14:36IST

Market cap

₹42 Cr

Revenue (TTM)

₹79 Cr

P/E Ratio

83.6

P/B Ratio

1.5

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Operating Revenue	78.77	36.96	34.08	18.73	--	--
Total Income	78.79	37.06	34.11	18.92	--	--
Total Expenditure	74.96	34.14	31.26	17.58	--	--
EBITDA	3.82	2.82	2.82	1.15	--	--
Depreciation	0.72	0.61	0.73	0.59	--	--
EBIT	3.09	2.21	2.09	0.57	--	--
Interest	1.46	0.99	0.93	0.43	--	--
Other Income	0.02	0.09	0.03	0.19	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	1.65	1.32	1.19	0.33	--	--
Provision for Tax	0.47	0.32	0.24	0.07	--	--
Profit after Tax	1.18	0.99	0.95	0.26	--	--
Minority Interest	-0.68	-0.45	-0.43	--	--	--
Share of Associate	--	--	--	--	--	--
Consolidated Profit	0.50	0.55	0.52	0.26	--	--

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Shareholder's Funds	26.78	12.65	12.28	3.08	--	--
Minority Interest	-0.68	3.17	2.79	2.05	--	--
Non-Current Liabilities	10.17	9.06	5.26	7.69	--	--
Current Liabilities	34.32	14.03	12.24	7.35	--	--
Total Liabilities	75.86	38.92	32.56	20.17	--	--

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Non-Current Assets	15.22	8.03	5.98	5.10	--	--
Current Assets	56.99	30.88	26.56	15.06	--	--
Total Assets	75.86	38.92	32.56	20.17	--	--
Total Debt*	--	17.15	12.70	14.20	--	--
Net Current Assets	22.67	16.85	14.33	7.71	--	--
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Cash From Operating Activities	--	-4.93	-4.13	-1.10	--	--
Cash Flow from Investing Activities	--	-0.08	-1.58	-5.30	--	--
Cash from Financing Activities	--	5.09	5.59	4.47	--	--
Net Cash Inflow / Outflow	--	0.08	-0.11	-1.93	--	--

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Adjusted EPS (₹)	0.29	0.46	0.43	0.30	--	--
Cash EPS (₹)	0.28	1.34	1.40	0.98	--	--
Adjusted Book Value (₹)	15.28	10.54	10.22	3.56	--	--
Dividend per Share (₹)	--	0.10	0.10	0.03	--	--
Cash Flow per Share (₹)	--	-4.11	-3.44	-3.66	--	--
Free Cash Flow per Share (₹)	--	-4.99	-5.57	-23.01	--	--

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
ROCE (%)	--	8.41	10.04	4.39	--	--
ROE (%)	2.53	7.98	12.36	8.40	--	--
ROA (%)	2.06	2.78	3.59	1.28	--	--
EBIT Margin (%)	3.93	5.98	6.13	3.03	--	--
Net Margin (%)	1.50	2.68	2.78	1.36	--	--
Cash Profit Margin (%)	--	4.35	4.92	4.50	--	--

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Revenue Growth (%)	133.74	8.47	81.93	--	--	--
EBIT Growth (%)	59.52	5.82	267.75	--	--	--
Net Profit Growth (%)	-1,131.40	4.86	267.90	--	--	--
EPS Growth (%)	-885.00	4.88	45.35	--	--	--
Book Value Growth (%)	--	3.06	299.94	--	--	--

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Price / Earnings	83.62	101.80	85.33	29.56	--	--
Price / Book Value	1.53	4.40	3.62	7.13	--	--
Dividend Yield (%)	--	0.22	0.27	0.14	--	--
EV/EBITDA	16.98	24.93	20.05	26.75	--	--
Close Price (₹)	28.88	46.37	37.06	25.38	--	--
High Price (₹)	49.70	63.14	47.76	25.38	--	--
Low Price (₹)	22.00	28.31	24.00	7.57	--	--
Market Cap (₹ Cr)	41.89	55.65	44.47	21.88	--	--

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Debt to Equity	0.38	1.36	1.04	4.63	--	--
Short term debt to equity ratio	--	0.65	0.61	2.13	--	--
Current Ratio	1.66	2.20	2.17	2.05	--	--
Quick Ratio	1.28	1.59	1.64	1.68	--	--
Interest Coverage	2.13	2.33	2.27	1.75	--	--

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Debtors to sales (%)	39.80	50.74	42.61	35.35	--	--
Asset Turnover	1.37	1.03	1.29	0.93	--	--
Receivable days	--	164.30	113.22	129.01	--	--
Inventory Days	--	73.93	49.16	52.83	--	--
Payable days	--	52.71	29.10	5.40	--	--
Cash Conversion Cycle	--	185.52	133.28	176.44	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement (₹ Cr)